This feature is available to journalist, bloggers and other members of the media. You must be logged into ReleaseWire to take advantage of this service.
International Stem Cell Corporation’s (ISCO) - Expects to begin human clinical trials using parthenogenetic neural stem cells that have the potential to treat and maybe even cure Parkinson’s disease.